Home
Goldman Sachs Group reported a 7.2% stake in Translational Development Acquisition TDAC · 1,056,879 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 7.2%
- Last report
- 6.1% · filed 26/05/13
- Shares held
- 1,056,879 sh
- Class
- Class A ordinary shares, $0.0001 par value per share
- Holder
- Goldman Sachs Group
- Event date
- 26/06/30
- Filed
- 26/08/12
7.2% stake · +1.1pp from the last report
- Stake
- 7.2%
- Last report
- 6.1%
- Since last report
- +1.1pp
Translational Development Acquisition trades, last 26 weeks
What else happened in Translational Development Acquisition around then
Filed or reported within 30 days of the trade day · 05/31~07/30Goldman Sachs Group's other 5% stake reports
- Goldman Sachs Group
5% stakeFuture Money Acquisition
5% stakeFuture Money Acquisition
FMAC
7.5% stake
1,184,873 sh
7.5% stake
Filed 08/14
- Goldman Sachs Group
5% stakeBreeze Acquisition Corp. II
5% stakeBreeze Acquisition Corp. II
BREZ
6.7% stake
970,701 sh
6.7% stake
Filed 08/14
- Goldman Sachs Group
5% stakeAmerican Exceptionalism Acquisition Corp. A
5% stakeAmerican Exceptionalism Acquisition Corp. A
AEXA
4.2% stake
1,444,735 sh
4.2% stake
Filed 08/14
- Goldman Sachs Group
5% stakeApex Tech Acquisition
5% stakeApex Tech Acquisition
TRAD
7.6% stake
1,076,558 sh
7.6% stake
Filed 08/14
- Goldman Sachs Group
5% stakeTango Therapeutics
5% stakeTango Therapeutics
TNGX
6% stake
9,742,402.8 sh
6% stake
Filed 08/14
